Please assess the completion status of the following clinical trial:

Trial Title: Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Documented inoperable, histologically confirmed NSCLC stage III~* Sufficient remaining lung function (FeV1\>1.5 l/s or at least 50 % of the respective individual norm value)~* Karnofsky Performance Score of 70 % or higher.~* Patients \> 18 years of age.~* Adequate haematological function (wbc\>3000 x 10\^3 /ml, thc \>100 ×10\^6 /ml, Hb\>10 g/dl)~* Adequate hepatic and renal function~* Written informed consent~Exclusion Criteria:~* Patient refusal~* Severe concurrent systemic disease~* Claustrophobia~* Cardiac pacemaker~* Other malignancies~* Hypersensitivity to x-ray contrast medium or 18F-FMISO~* Severe renal or hepatic insufficiency~* NSCLC stage I, II or IV~* Pregnancy or lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Multimodal hypoxia imaging (Type: OTHER): Patients with inoperable, stage III non-small cell lung cancer receive serial 18F-FMISO dPET-CT and functional MRI investigations prior, during and post radiation treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).